Nektar Therapeutics
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2019 | 81.4% | -383.9% | -384.5% |
| FY2020 | 87.3% | -278.0% | -290.6% |
| FY2021 | 75.6% | -437.8% | -514.0% |
| FY2022 | 76.5% | -408.6% | -400.0% |
| FY2023 | 62.5% | -292.6% | -306.3% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2019 | 81.4% | -383.9% | -384.5% |
| FY2020 | 87.3% | -278.0% | -290.6% |
| FY2021 | 75.6% | -437.8% | -514.0% |
| FY2022 | 76.5% | -408.6% | -400.0% |
| FY2023 | 62.5% | -292.6% | -306.3% |